Alphamino
alphamino.co.uk
Email me when this record changes
Following this record emails you when it gains a dated entry or its published claims are re-read, and nothing about any other supplier. No topic below is ticked: tick one only if you also want it in the same email.
2 recorded documentation gaps also on file, subtracted from the score.
Compiled automatically from the dated observations in this vendor's record. How we evaluate.
Never merged into one number. Some supplier links here are referral links, marked where they appear, which pay Terminus Research when a reader buys. The same terms are open to every supplier in the ledger, apart from the one exception the referral policy page names, participation changes no score, rank, caution, or coverage decision, and a link is not an endorsement.
Alphamino's current catalog holds no retatrutide product; the compound's only trace is two blog posts embedding self-hosted Janoshik certificate images for lots ALPRT1001 and ALPRT1002, the same compound named two ways, "Retatrutide 10mg" and "Alphamino GL3-R 10mg," and a third page for a further lot, ALPRT2001, carrying a PeptideVerify certificate that answers live from its issuer's API at 99.02 percent purity by HPLC single peak, its own peak purity index measure, no mass-spectrometric identity performed. The About page states that "where applicable" batches are verified "through Janoshik independent analysis" with certificates "linked from the product page," but the certificates embedded on the five of its fifteen current products that carry one, GHK-Cu, MOTS-c, MT-II, BPC-157 and TB-500, split between Janoshik and a UK-registered service called PeptideVerify, whose certificate faces state which tier applies, mass-spectrometric identity confirmation or HPLC purity alone. A reader who bought retatrutide, or the same compound under its GL3-R house code, could say whether it was ever a generally available listing or a one-off batch.
What the record holds
NO FIRM COMMITMENT
“Shipping is UK-only with tracking on every order and free standard delivery on orders over GBP 200”
Scope, tracking and a free-delivery threshold are stated on the About and Contact pages, but no dispatch cutoff, processing window or carrier is published anywhere fetched; no international shipping is mentioned.
Read from this supplier's own pages on 2026-08-26. This publication has never placed an order with any supplier. This row records what is written and measures nothing about what actually happens after an order.
Compound retatrutide: no product exists in the current catalogue at any strength or packaging
Listed as Not listed for sale. The compound appears only in two lab-report blog posts, titled 'Alphamino Retatrutide 10mg' and 'Alphamino GL3-R 10mg', each linking to a Janoshik test page rather than a product page
Price as recorded No price is published for retatrutide in any form; the site's fifteen current catalogue items are all priced in pounds sterling, spanning a low-to-high range detailed in the entries above, before the sale reductions noted there
Read on 2026-08-26. One reading on one day, and prices are not tracked over time here.
This supplier was not part of the Trustpilot reading of 2026-08-25, which covered 59 of the 126 suppliers on file. That is a fact about this publication's coverage, stated rather than left to be read either way.
6 claims from this publication's own dossier on this supplier were read again against the live site on 2026-08-26: 1 held, 5 corrected before publication.
A corrected claim is an error of ours that the re-read caught before it reached a page. This line tracks this publication's own accuracy. It says nothing about the supplier.
Dated entries
4 observations on file, recorded 2026-08-26. Newest first, appended and never rewritten.
Fetched today. Alphamino is a UK WooCommerce storefront (currency GBP throughout). The catalogue, confirmed against /product-sitemap.xml and the /shop/ listing's own count of fifteen items, holds fifteen entries and no retatrutide and no tirzepatide product page exists among them: NAD+ Research-Grade (variants, GBP 34.50 to 55.00), Klow Stack (GBP 55.50, reduced from 58.50), MT II (GBP 22.50), CJC + IPA (GBP 38.00, reduced from 39.50), Selank (GBP 18.00 to 29.99), MOTS-c (GBP 25.00), Tesamorelin (GBP 52.50), Bacteriostatic Water (GBP 5.00 to 9.00), GHK-Cu (GBP 24.50 to 35.00), IGF-1 LR3 (GBP 48.00), BPC-157 (GBP 18.00 to 30.00), Semax (GBP 12.00 to 29.99), TB-500 (GBP 20.00 to 30.00), SS-31 (GBP 28.00, reduced from 29.99) and Glow Stack (GBP 55.00). A site search for retatrutide, however, returns two live blog posts rather than a product page: 'Janoshik Test Report - ALPRT1001 - Alphamino Retatrutide 10mg' (published 2025-11-14, last modified 2026-05-11) linking out to janoshik.com/tests/90167-Retatrutide_10_mg_M1UZEXKV3CBW, and 'Janoshik Test Report - ALPRT1002 - Alphamino GL3-R 10mg' (published 2026-04-04, last modified 2026-04-24) linking to janoshik.com/tests/149103-Retatrutide_10mg_7W3ZMQQQRPDV, the same compound under two different product names across the two lot references. Both posts embed the full Janoshik document as a self-hosted image on alphamino.co.uk, legible without ever reaching janoshik.com, and no current product listing, price or stock status accompanies either. The ALPRT1001 post embeds task 90167: client Alphamino, manufacturer Alphamino, sample Retatrutide 10 mg, batch ALPRT1001, ordered 18 NOV '25, received 24 NOV '25, analysed 26 NOV 2025, 10.48 mg reported against a 10 mg label, purity 99.453 percent, the certificate face naming no analytical method. The ALPRT1002 post embeds task 149103: client Anonymous rather than Alphamino, manufacturer Alphamino, sample Retatrutide 10mg, batch ALPRT1002, ordered 17 APR '26, received 22 APR '26, analysed 24 APR 2026, 10.74 mg against a 10 mg label, purity 99.515 percent, again with no method named on the face, its tests-requested field naming a blind panel covering semaglutide, tirzepatide and retatrutide together. I could not open either outbound Janoshik URL directly, the main janoshik.com host failing the TLS handshake from this environment (the same failure recorded against verify.janoshik.com in prior waves), so those figures are read from the vendor's self-hosted images rather than the laboratory's database. The ALPRT1001 post also carries a hidden second outbound link: the first character of its one visible URL is its own anchor pointing at a tirzepatide Janoshik record (task 90168), which is why the site's own search for tirzepatide returns this retatrutide page. Nor are the two posts the whole paper trail: a third live page listed in the site's own page sitemap, /test-report-alprt2001-alphamino-gl3-r-20mg/, titled 'Test Report - ALPRT2001 - Alphamino GL3-R 20mg', links a PeptideVerify certificate (PV-690108-5RMU) that answers from its issuer's own API today: customer Alphamino, expected peptide Retatrutide, batch ALPRT2001, purity 99.02 percent by HPLC single peak (the document's own Peak Purity Index measure), no mass-spectrometric identity performed, the document also self-hosted on the vendor's domain as a downloadable PDF. That third page is surfaced by an on-site search for the house code gl3-r but not by a search for retatrutide. As read today, Alphamino does not sell retatrutide at any strength; the compound's on-site trace is three lab-report pages, two linking an unreachable third party while embedding legible self-hosted copies of the documents, and a third carrying a certificate checkable at its issuer.
On the labs actually used for the products Alphamino does sell. The GHK-Cu, MOTS-c and MT-II product pages each embed a certificate image (filenamed with a COA-PV-xxxxxx prefix) from a service called PeptideVerify. I opened the GHK-Cu image directly: report PV-26E0C9-NSUV, prepared for ALPHAMINO, batch ALPGC5003, analysed 15/06/2026, method HPLC-UV at 215nm on a Shimadzu LCMS-8040, single peak at retention time 2.485 min, purity 99.3 percent (the document's own Peak Purity Index measure), and the certificate states plainly on its face that 'Identity - LC-MS: NOT INCLUDED. This is a Standard (HPLC purity) certificate,' naming a higher Combined tier as the one that would include mass-spectrometric identity. PeptideVerify is independently locatable and operated by a UK-registered company: www.peptideverify.co.uk (peptideverify.co.uk redirects to it) is live, names the operating entity as Verify Analytik Ltd, Company No. 17110285, registered at London BioScience Innovation Centre, 2 Royal College Street, London NW1 0NH, and states on its own homepage that because it sells no peptides itself, it has no stake in what any certificate finds. Rather than rely on the page's client-rendered verify widget, which ships every possible UI state (not-found, withdrawn, verified) in the same static markup and cannot be read by a plain fetch, I queried the site's own certificate API directly (www.peptideverify.co.uk/api/certificate/PV-26E0C9-NSUV) and it returned success true with a full analytical record matching the image exactly: customer ALPHAMINO, batch ALPGC5003, single peak, purity 99.3, identity verdict 'not_applicable' because no mass spectrometry was ordered for this sample. I ran the same API check against the certificate ID implied by the MOTS-c product page's filename (PV-55A466-PWCR) and it also returned success true, this time serviceType 'combined' with identity confirmed by mass spectrometry (three matched charge states, [M+2H]2+, [M+3H]3+ and [M+4H]4+, deconvoluting to one intact mass; a fourth detected spectral peak in the raw feed sits outside the charge-state match and is no part of the confirmation), purity 99.27 percent, batch ALPMC1003, tested the same day, 15/06/2026. So the testing tier genuinely differs by product on this site (HPLC-only for GHK-Cu, HPLC plus LC-MS for MOTS-c) and the vendor discloses which tier applies on the certificate face rather than asserting identity confirmation across the board.
On price, catalogue framing, payment, shipping and entity identity. Since no retatrutide product exists on this site, there is no retatrutide price to record; the closest comparable figures are the fifteen catalogue prices above, all in pounds sterling. Payment is stated on the Contact page as 'Card, PayPal, Bitcoin.' Shipping is UK-only with tracking on every order and free standard delivery on orders over GBP 200, per both the About and Contact pages; no international shipping is mentioned anywhere I fetched. The About page gives a street address, 'Unit A82, James Carter Road, Mildenhall, IP28 7DE, United Kingdom' (repeated on the Contact page split as Unit A, 82 James Carter Road), an email (info@alphamino.co.uk) and stated hours (Monday to Friday, 08:30 to 18:00 UK time), but no telephone number and no company registration number on either page. The About page's own quality-and-documentation section is hedged rather than blanket: 'Third-party testing: Where applicable, batches are verified through Janoshik independent analysis with Certificates of Analysis (COA) linked from the product page for the batch in stock' (Janoshik is named here even though the certificates I actually opened on live product pages were PeptideVerify documents, not Janoshik ones, so the About page's own naming of its testing partner does not match what the GHK-Cu and MOTS-c pages actually link), and the GHK-Cu product page itself states independently that 'Independent third-party testing may not be performed on every small batch; third-party reports are supplied only when released for a specific lot.' The refund and returns page (/refund_returns/) allows a 30-day return window for eligible items but excludes 'any and all Peptide products' and 'Peptide vials, even unopened' by name, sets a 48-hour window to report a damaged or incorrect item, and states approved refunds complete within 7 to 10 business days. Research-use and age-gate language is present sitewide as a footer block on every page fetched, plus a full-screen 18-plus entry gate, and repeats MHRA and FDA non-evaluation language by name.
CAUTIONCautions noted. First, certificate coverage is thinner and more mixed than the About page's wording implies: of the fifteen live products, only five carry any certificate on their product page, three from PeptideVerify (GHK-Cu, MOTS-c and MT-II) and two self-hosted Janoshik documents embedded on the BPC-157 and TB-500 pages (batch ALPBP501, 5.86 mg against a 5mg label at purity 99.885 percent, and batch ALPTB501, 5.66 mg against a 5mg label at purity 99.831 percent, both by the lab's own peptide-content assay with no method named on the certificate face, both analysed 27 APR 2026), while the remaining ten products carry none, which is what the GHK-Cu page's own hedge about testing not being performed on every small batch actually describes. Both named labs also appear on both sides of the catalogue line, Janoshik on two current product pages as well as the orphaned retatrutide posts, and PeptideVerify on three current pages as well as the discontinued ALPRT2001 retatrutide lot. Second, retatrutide is advertised nowhere as a current product, yet three lab-report pages referencing it remain live, two indexed by the site's own search for the compound name (one modified as recently as 2026-05-11, six months after it was first published and roughly nine and a half months before today) and a third, the ALPRT2001 page, surfaced only by searching the house code gl3-r; a visitor who finds these pages through search has no way to learn from the site itself whether the underlying product was ever generally available, is discontinued, or was a one-off batch, since none of the three carries a product link, a price, or a discontinuation notice. Third, the same compound is named two different ways across the two posts, 'Retatrutide 10mg' in one and 'GL3-R 10mg' in the other, an inconsistency of the same kind flagged for other vendors' duplicate retatrutide listings in prior waves of this ledger. Fourth, the site publishes a reconstitution and concentration calculator at /calculator/ that accepts a peptide mass, a bacteriostatic-water volume and a required sample size in milligrams or micrograms, and returns a solution concentration, a volume to draw and graduated U-100 syringe units (IU), the same class of syringe-unit dosing-arithmetic tool flagged as a caution for other vendors in this ledger (Luxara Labs, wave prior); the page's own disclaimer frames the output as being for in-vitro research planning, but the literal output is a syringe draw volume in IU, the unit a human self-injector reads off an insulin syringe. Fifth, the janoshik.com host could not be reached directly from this environment (a TLS-handshake failure on the main domain, distinct from though consistent with the Cloudflare-challenge block recorded against verify.janoshik.com in earlier waves), so the two Janoshik-linked retatrutide certificates could not be checked against the laboratory's own database; their figures are read from the full report images the posts self-host on the vendor's own domain, detailed above, while the third retatrutide certificate, PeptideVerify's PV-690108-5RMU, does answer from its issuer's own API today.
Reader reviews
No reader review of this supplier is published yet. Every review is read and checked against the record before it appears. Add a review.
Open this supplier
Some supplier links here are referral links, marked where they appear, which pay Terminus Research when a reader buys. The same terms are open to every supplier in the ledger, apart from the one exception the referral policy page names, participation changes no score, rank, caution, or coverage decision, and a link is not an endorsement.